Advertisement
Boston Scientific
Subscribe to Boston Scientific
View Sample

FREE Email Newsletter

Boston Scientific saw 5% revenue growth at end of 2013

February 5, 2014 2:00 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

Delivering his first annual report after a full year as head of the state’s largest medical device company, CEO Mike Mahoney reported that the last three months of 2013 saw revenues rise 5 percent over the previous year, providing what he...

Boston Scientific Launches OffRoad Re-Entry Catheter System

February 5, 2014 9:50 am | by PR Newswire | News | Comments

Boston Scientific has announced the U.S. launch and first use of the OffRoad Re-Entry Catheter System, an important addition to the company's portfolio of tools to treat complete arterial blockages in the major arteries of the legs. These...

Stent wars: Shrinkage concerns resurface in Medtronic/Boston Scientific DES trial

February 3, 2014 2:20 pm | by Mass Device | News | Comments

Medtech giants Medtronic and Boston Scientific took their long-time stent rivalry to new heights in a 1st-of-its-kind head-to-head study of their next-generation drug-eluting stents, with researchers ultimately reporting little difference...

Advertisement

Boston Scientific names new medical chief for interventional cardiology

January 6, 2014 1:21 pm | by Mass Device | News | Comments

Boston Scientific today announced the appointment of Dr. Craig Thompson as senior vice president and chief medical officer for the medtech giant's interventional cardiology business. Thompson hopes to "further develop the technology...  

CE Mark and First Implants of Boston Scientific’s X4 Quadripolar CRT-D Systems

December 17, 2013 10:02 am | by PR Newswire | News | Comments

Boston Scientific Corporation has received CE Mark approval of its X4 line of quadripolar CRT-D systems, including the AUTOGEN X4, DYNAGEN X4, and INOGEN X4 cardiac resynchronization therapy defibrillators (CRT-Ds), a suite of ACUITY X4... 

Henry Ford Hospital Implants New Defibrillator for People at Risk of Sudden Cardiac Arrest

December 16, 2013 1:12 pm | by PR Newswire | News | Comments

A new internal defibrillator, on the cusp of a new standard of care in American cardiology to treat patients for a major heart risk, is being used at Henry Ford Hospital. Compared to the current devices used to treat sudden cardiac arrest...

FDA Advisory Panel Votes Favorably on the Boston Scientific WATCHMAN™ Left Atrial Appendage Closure Device

December 11, 2013 7:49 pm | by PR Newswire | News | Comments

The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted favorably by a majority, Yes: 13, No: 1, that the benefits of the WATCHMAN Left Atrial Appendage Closure device... 

Vascular Solutions claims a win against Boston Scientific

December 10, 2013 3:18 pm | by Mass Device | News | Comments

Vascular Solutions claimed a win in its patent infringement lawsuit against Boston Scientific over the Guidezilla catheter, saying a federal judge granted a preliminary injunction against U.S. sales of the BSX device. Vascular Solutions sued...

Advertisement

Revisit Your Patent Licensing Practices Now

December 10, 2013 1:58 pm | by Orion Armon, Partner, Cooley LLP | Blogs | Comments

If your company licenses patented technology (in or out), it is time to revisit your licensing practices in light of recent (and anticipated) changes in patent law. In 2007, the U.S. Supreme Court held in MedImmune, Inc. v. Genentech, Inc...

Boston Scientific faces more questions over Watchman implant's effectiveness, risks

December 9, 2013 3:00 pm | by Mass Device | News | Comments

Boston Scientific may have to confront some tough questions when it faces a panel of FDA experts reviewing its Watchman stroke-preventing heart implant. In panel documents released ahead of this week's meeting, the FDA asked its advisory...

Boston Scientific touts high success rate, pain reduction with Precision Spectra spinal cord stim

December 6, 2013 2:00 pm | by Mass Device | News | Comments

Boston Scientific unveiled new 3-month results on its Precision Spectra spinal cord stimulation system, saying the implant resulted in significant pain reduction at 3 months and an overall success rate of 94%. The report came from a retrospective...

Boston Scientific Receives FDA Approval for Coronary Stent System

November 26, 2013 10:25 am | by PR Newswire | News | Comments

Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation has received U.S. Food and Drug Administration (FDA) approval for the Promus PREMIER™ Everolimus-Eluting Platinum Chromium Coronary Stent System...

Abiomed loses IR exec to Boston Scientific | Personnel Moves

November 22, 2013 11:36 am | by Mass Device | News | Comments

Susan Vissers Lisa, the former director of investor relations at Abiomed, was named vice president of IR at Boston Scientific. Apart from her most recent role at Abiomed, Lisa's résumé includes stints at Bank of America Merrill Lynch, Cowen & Co...

Advertisement

Boston Scientific Receives FDA Clearance And CE Mark Approval For Direxion Torqueable Microcatheter

November 19, 2013 6:02 pm | by PR Newswire | News | Comments

Further bolstering its market-leading portfolio of peripheral embolization technologies, Boston Scientific Corporation has received U.S. Food and Drug Administration clearance and CE Mark approval for its Direxion Torqueable Microcatheter...

Unexpectedly strong ICD sales for Medtronic buoy Boston Scientific

November 19, 2013 9:59 am | by Mass Device | News | Comments

Medtronic posted stronger-than-expected U.S. sales growth for its implantable cardioverter defibrillators, buoying shares of ICD rival Boston Scientific. Medtronic's U.S. ICD sales grew 3.9% during its fiscal 2014 2nd quarter ended Oct. 25, rising...

Boston Scientific adds dystonia indication to CE Mark for Vercise DBS device

November 19, 2013 9:02 am | by Mass Device | News | Comments

Boston Scientific said it won CE Mark approval in the European Union for its Vercise deep-brain stimulation device for treating the movement disorder called dystonia. The Vercise device is already approved in the EU for treating Parkinson's...

Meeting Notice: December 11, 2013 Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting Announcement

November 12, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments

On December 11, 2013, the committee will discuss, make recommendations, and vote on information related to the premarket approval application regarding the Boston Scientific WATCHMAN Left Atrial Appendage (LAA) Closure Technology. The WATCHMAN...

Boston Scientific leads $20M financing round for Sensible Medical

November 11, 2013 3:48 pm | by Mass Device | News | Comments

Sensible Medical raised $20 million in its latest financing round, with investment led by Boston Scientific. Lowell, Mass.-based Boston Scientific is also working on launch for Sensible Medical's flagship product, a non-invasive thoracic fluid status...

Boston Scientific Completes Acquisition of Bard Electrophysiology

November 1, 2013 12:07 pm | by PR Newswire | News | Comments

Boston Scientific Corporation closed on its previously announced agreement to acquire Bard EP, the electrophysiology (EP) business of C.R. Bard, Inc. The completion of this transaction advances Boston Scientific's ability to more comprehensively...

Data: Significant and Sustained Blood Pressure Reduction with Boston Scientific’s Renal Denervation System

October 29, 2013 11:37 am | by PR Newswire | News | Comments

Patients treated with the Boston Scientific Vessix Renal Denervation System experienced a significant and sustained reduction in blood pressure, according to new data presented today at the Transcatheter Cardiovascular Therapeutics (TCT)...

Boston Scientific Receives CE Mark for Lotus Valve System

October 28, 2013 2:09 pm | by PR Newswire | News | Comments

Boston Scientific Corporation has received CE Mark for the Lotus™ Valve System, the company's advanced transcatheter aortic valve replacement (TAVR) technology.  This key approval offers a unique and effective new treatment alternative for...

Layoffs: Boston Scientific to cut up to 1,500 jobs

October 23, 2013 7:38 pm | by Mass Device | News | Comments

In regulatory filings issued late Wednesday evening Boston Scientific announced that it plans to cut up to 1,500 employees from its global workforce before the end of 2015. The cuts are part of the company's plan to streamline operations, including...

Boston Scientific Alair Bronchial Thermoplasty System Approved In China

October 23, 2013 4:30 pm | by PR Newswire | News | Comments

Boston Scientific Corporation has received China Food and Drug Administration approval for the Alair® Bronchial Thermoplasty System, an innovative medical device designed to treat severe asthma.  Expected to be available in the China market...

Boston Scientific, Guidant to Pay $30M Settlement

October 18, 2013 1:52 pm | by The Associated Press | News | Comments

The Justice Department says Boston Scientific Corp. and its Guidant subsidiaries will pay $30 million to settle allegations that Guidant knowingly sold defective heart devices that health care facilities implanted in Medicare patients from 2002 to 2005...

Boston Scientific Begins Clinical Trial of Peripheral Vascular Drug-Eluting Stent System

October 10, 2013 11:16 am | by PR Newswire | News | Comments

Launching a key clinical trial expected to serve as the foundation for global regulatory approvals, a physician in Auckland, New Zealand has performed the first patient implant of the Boston Scientific Innova Drug-Eluting Stent (DES) System...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading